Identification of recurrent FGFR3-TACC3 fusion oncogenes from lung adenocarcinoma.

  title={Identification of recurrent FGFR3-TACC3 fusion oncogenes from lung adenocarcinoma.},
  author={Marzia Capelletti and Michael E. Dodge and Dalia Ercan and Peter S. Hammerman and Seung Il Park and Jhingook Kim and Hidefumi Sasaki and David Mark Jablons and Doron M Lipson and Lauren E. Young and Phil J. Stephens and Vincent A. Miller and Neal I Lindeman and Kiara J. Munir and William G. Richards and Pasi Antero J{\"a}nne},
  journal={Clinical cancer research : an official journal of the American Association for Cancer Research},
  volume={20 24},
PURPOSE Targetable oncogenic alterations are detected more commonly in patients with non-small cell lung cancer (NSCLC) who never smoked cigarettes. For such patients, specific kinase inhibitors have emerged as effective clinical treatments. However, the currently known oncogenic alterations do not account for all never smokers who develop NSCLC. We sought… CONTINUE READING